Hepatotoxicity Associated With Antiretroviral Therapy in Adults Infected With Human Immunodeficiency Virus and the Role of Hepatitis C or B Virus Infection
Top Cited Papers
Open Access
- 5 January 2000
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 283 (1), 74-80
- https://doi.org/10.1001/jama.283.1.74
Abstract
Abnormal levels of liver enzymes are common among persons infected with human immunodeficiency virus (HIV), and may be caused by multiple factors, including medication toxicity and coinfection with hepatitis C virus (HCV) or hepatitis B virus (HBV).1-3 Coinfection with HCV and HIV is common, occurring in 50% to 80% of individuals who acquired HIV through parenteral exposures. Chronic HBV infection occurs in 10% to 15% of persons infected with HIV.2,4Keywords
This publication has 22 references indexed in Scilit:
- Hepatotoxicity after introduction of highly active antiretroviral therapyAIDS, 1998
- A Preliminary Evaluation of Nelfinavir Mesylate, an Inhibitor of Human Immunodeficiency Virus (HIV)‐1 Protease, to Treat HIV InfectionThe Journal of Infectious Diseases, 1998
- Value of epidemiologic studies in determining the true incidence of adverse events. The nonsteroidal anti-inflammatory drug storyArchives of Internal Medicine, 1997
- Severe hepatitis in patients with AIDS and haemophilia B treated with indinavirThe Lancet, 1997
- Severe hepatitis in three AIDS patients treated with indinavirThe Lancet, 1997
- Reciprocal Interactions Between Human Immunodeficiency Virus and Hepatitis C Virus InfectionsClinical Infectious Diseases, 1996
- Adverse Events from Drug Therapy for Human Immunodeficiency Virus DiseaseAmerican Journal Of Medicine, 1996
- Racial Differences in the Use of Drug Therapy for HIV Disease in an Urban CommunityNew England Journal of Medicine, 1994
- Interactions and Toxicities of Drugs Used in Patients with AIDSClinical Infectious Diseases, 1992
- The Influence of Human Immunodeficiency Virus Type 1 Infection on the Development of the Hepatitis B Virus Carrier StateThe Journal of Infectious Diseases, 1991